We are live on ! Find out more
HOWL icon

Werewolf Therapeutics
HOWL

46 hedge funds and large institutions have $78M invested in Werewolf Therapeutics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.19% more ownership

Funds ownership: 68.79% → 68.98% (+0.19%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less funds holding

Funds holding: 49 → 46 (-3)

7% less capital invested

Capital invested by funds: $84.3M → $78M (-$6.25M)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

53% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 15

Holders
46
Holders Change
-3
Holders Change %
-6.12%
% of All Funds
0.77%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
7
Reduced
15
Closed
16
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$5.23M
2
LCM
Laurion Capital Management
New York
+$2.44M
3
OMC
Oasis Management Company
Cayman Islands
+$1.12M
4
Millennium Management
Millennium Management
New York
+$942K
5
RCMNY
Rubric Capital Management (New York)
New York
+$935K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$5.02M
2
State Street
State Street
Massachusetts
-$1.42M
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$954K
4
Northern Trust
Northern Trust
Illinois
-$827K
5
MIFH
Migdal Insurance & Financial Holdings
Israel
-$825K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$69K +$76.7K +16,800 New
Northern Trust
27
Northern Trust
Illinois
$57K -$827K -181,250 -93%
CSS
28
Cubist Systematic Strategies
Connecticut
$54K +$60.5K +13,250 New
Goldman Sachs
29
Goldman Sachs
New York
$45K -$3.07K -672 -6%
YIH
30
Y-Intercept (HK)
Hong Kong
$45K +$50.8K +11,124 New
UBS Group
31
UBS Group
Switzerland
$18K +$9.83K +2,154 +102%
JP Morgan Chase
32
JP Morgan Chase
New York
$15K -$54.4K -11,929 -76%
Bank of America
33
Bank of America
North Carolina
$11K -$89.5K -19,623 -88%
TRCT
34
Tower Research Capital (TRC)
New York
$10K -$1.71K -374 -14%
Citigroup
35
Citigroup
New York
$3K -$8.88K -1,946 -73%
OLVIG
36
Oliver Lagore Vanvalin Investment Group
Michigan
$2K – – –
FP
37
Financial Perspectives
Minnesota
$1.02K – – –
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$1K -$63.3K -13,866 -99%
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$1K -$6.34K -1,389 -86%
MIFH
40
Migdal Insurance & Financial Holdings
Israel
– -$825K -187,500 Closed
Bank of New York Mellon
41
Bank of New York Mellon
New York
– -$301K -68,338 Closed
Charles Schwab
42
Charles Schwab
California
– -$267K -60,646 Closed
GPCM
43
Granite Point Capital Management
Massachusetts
– -$242K -55,000 Closed
EWM
44
Evercore Wealth Management
New York
– -$205K -46,500 Closed
N
45
Nuveen
North Carolina
– -$731K -36,879 Closed
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
– -$99K -22,550 Closed
Citadel Advisors
47
Citadel Advisors
Florida
– -$89K -20,144 Closed
Two Sigma Investments
48
Two Sigma Investments
New York
– -$67K -15,180 Closed
Deutsche Bank
49
Deutsche Bank
Germany
– -$63K -14,349 Closed
AIG
50
American International Group
New York
– -$58K -13,111 Closed
1
2
3

HOWL Hedge Fund Activity: Q2 2022 in Review

46 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Werewolf Therapeutics (HOWL) for Q2 2022, worth a combined $78M — down 7.4% from $84.3M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of HOWL and 14 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 7 added.

The largest buyer was PFM Health Sciences, adding an estimated $5.23M. The largest seller was BlackRock, cutting an estimated $5.02M.

  • 46 institutional investors held Werewolf Therapeutics (HOWL) as of Q2 2022, down from 49 in Q1 2022.
  • Funds reported $78M of Werewolf Therapeutics stock for Q2 2022, down 7.4% quarter-over-quarter.
  • 14 funds opened new Werewolf Therapeutics positions in Q2 2022 and 16 closed out, a net change of -2 holders.
  • The largest Werewolf Therapeutics buyer in Q2 2022 was PFM Health Sciences, an estimated $5.23M added.
  • The largest Werewolf Therapeutics seller in Q2 2022 was BlackRock, an estimated $5.02M sold.

Based on aggregated 13F filings for Q2 2022.